Your browser doesn't support javascript.
loading
GJA1 reverses arsenic-induced EMT via modulating MAPK/ERK signaling pathway.
Wu, Linqing; Wang, Zengbin; He, Xiaoli; Jiang, Yayuan; Pan, Ruizhu; Chen, Shi; Chen, Yizhong; Han, Yanfei; Yu, Huahui; Zhang, Tao.
Afiliación
  • Wu L; Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Wang Z; Department of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Cancer Center of Fujian Medical University, Fujian Medical University Union Hospital, Fuzhou, China.
  • He X; Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Jiang Y; Xiamen Lotus Hospital, Xiamen, China.
  • Pan R; Fujian Fuqing Health School, China.
  • Chen S; Kindstar Global Medical Special Inspection Group, Wuhan, China.
  • Chen Y; Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Han Y; Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Yu H; Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Zhang T; Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China. Electronic address: zjdrzht@fjmu.edu.cn.
Toxicol Appl Pharmacol ; 450: 116138, 2022 09 01.
Article en En | MEDLINE | ID: mdl-35750204

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Arsénico / Transición Epitelial-Mesenquimal Límite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Arsénico / Transición Epitelial-Mesenquimal Límite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos